Viewing Study NCT00754494


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT00754494
Status: COMPLETED
Last Update Posted: 2015-01-06
First Post: 2008-09-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Sponsor: National Cancer Institute (NCI)
Organization: